Century Therapeutics (IPSC) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.72.
- Century Therapeutics' Equity Ratio rose 4310.95% to 0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72, marking a year-over-year increase of 4310.95%. This contributed to the annual value of 0.46 for FY2024, which is 1081.09% down from last year.
- Latest data reveals that Century Therapeutics reported Equity Ratio of 0.72 as of Q3 2025, which was up 4310.95% from 0.74 recorded in Q2 2025.
- Over the past 5 years, Century Therapeutics' Equity Ratio peaked at 0.76 during Q1 2025, and registered a low of 0.46 during Q4 2024.
- Moreover, its 4-year median value for Equity Ratio was 0.61 (2023), whereas its average is 0.61.
- Per our database at Business Quant, Century Therapeutics' Equity Ratio crashed by 1768.02% in 2023 and then surged by 4925.63% in 2025.
- Quarter analysis of 4 years shows Century Therapeutics' Equity Ratio stood at 0.62 in 2022, then fell by 17.68% to 0.51 in 2023, then dropped by 10.81% to 0.46 in 2024, then surged by 57.74% to 0.72 in 2025.
- Its last three reported values are 0.72 in Q3 2025, 0.74 for Q2 2025, and 0.76 during Q1 2025.